BenevolentAI, a London-based AI drug discovery company, laid off approximately 180 employees in May 2023 as part of a restructuring plan. The layoffs, which also involved cutting pipeline programs, were implemented to streamline operations and focus resources. While the exact percentage of the workforce affected is not specified, the move reflects broader challenges in the biotech and AI-driven pharmaceutical sectors, where companies often adjust strategies to prioritize core projects and ensure financial sustainability amid evolving market conditions.
